Also known as: Blood thinners - clopidogrel and Antiplatelet therapy - clopidogrel
- Prevent or treat heart attacks
- Prevent stroke or transient ischemic attacks (TIAs -- early warning signs of stroke, also called "mini-strokes")
- Increase blood flow to your legs
- Prevent clots from forming inside stents put inside your arteries to open them
- Skin rash
- Stomach pain
- You have bleeding problems or stomach ulcers.
- You are pregnant, plan to become pregnant, or are breastfeeding.
- Heparin and other blood thinners, such as warfarin (Coumadin)
- Pain or arthritis medicine (such as diclofenac, etodolac, ibuprofen, indomethacin, Advil, Aleve, Daypro, Dolobid, Feldene, Indocin, Motrin, Orudis, Relafen, or Voltaren)
- Phenytoin (Dilantin), tamoxifen (Nolvadex, Soltamox), tolbutamide (Orinase), or torasemide (Demadex)
- Take it as soon as possible, unless it is time for your next dose.
- If it is time for your next dose, take your usual amount.
- Do NOT take extra pills to make up for a dose you have missed, unless your doctor tells you to.
- Any signs of unusual bleeding, such as blood in the urine or stools, nosebleeds, any unusual bruising, heavy bleeding from cuts, black tarry stools, coughing up blood, heavier than usual menstrual bleeding or unexpected vaginal bleeding, vomit that looks like coffee grounds
- Difficulty swallowing
- Tightness in your chest or chest pain
- Swelling in your face or hands
- Itching, hives, or tingling in your face or hands
- Wheezing or difficulty breathing
- Very bad stomach pain
- Skin rash
Clopidogrel may be used to:
This medicine is taken as a pill. Your doctor may change your dose from time to time.
Side effects of this medicine may include:
Before you start taking clopidogrel, tell your health care provider if:
Take this medicine with food and plenty of water to reduce side effects. You may need to stop taking clopidogrel before you have surgery or dental work. Do NOT just stop taking your medicine without first talking with your health care provider.
Talk with your provider before taking any of these drugs:
Do not take other drugs that may have aspirin or ibuprofen in them before talking with your provider. Read the labels on cold and flu medicines. Ask what other medicines are safe for you to take for aches and pains, colds, or the flu.
Tell your provider if you are pregnant or planning to become pregnant, or breastfeeding or planning to breastfeed. Women in the later stages of pregnancy should not take clopidogrel. Clopidogrel can be passed to infants through breast milk.
If you miss a dose:
Store these drugs and all other medicines in a cool, dry place. Keep them where children cannot get to them.
When to Call the Doctor
Call if you have any of these side effects and they do not go away:
Abraham NS, Hlatky MA, Antman EM, et al.ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;122:2619-2633. PMID: 21060077 www.ncbi.nlm.nih.gov/pubmed/21060077.
Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354-471. PMID: 23166211 www.ncbi.nlm.nih.gov/pubmed/23166211.
Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007;116:2762-2772. PMID: 17998462 www.ncbi.nlm.nih.gov/pubmed/17998462.
Kushner FG, Hand M, Smith SC Jr, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:2271-2306. PMID: 19923169 www.ncbi.nlm.nih.gov/pubmed/19923169.
Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e601S-e636S. PMID: 22315273 www.ncbi.nlm.nih.gov/pubmed/22315273.
Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58:2432-2446. PMID: 22055990 www.ncbi.nlm.nih.gov/pubmed/22055990.
Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e637S-e68S. PMID: 22315274 www.ncbi.nlm.nih.gov/pubmed/22315274.
- Review date:
- December 08, 2014
- Reviewed by:
- Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.